Does metformin usage improve survival in head and neck squamous cell carcinoma? A population-based study

We sought to expand upon preliminary data suggesting that metformin confers a survival benefit to patients with head and neck squamous cell carcinoma (HNSCC).

https://ift.tt/2KRYixG